KEAP1 and Cognitive impairment: showed (66) that the walnut peptide YVLLPSPK improved learning and memory in scopolamine-induced cognitive impairment in mice through a mechanism related to the NF2/KEAP1/HO-1 pathway, providing a deeper theoretical basis for the research on the mechanisms by which walnut peptides improve learning memory and cognitive impairment.